DrugRepV_5377 | 2-deoxy-2-fluorocytidine | NA | NA | Lassa virus | Josiah | NA | Minigenome assays | Decrease (50 %) | NA | 27771389 |
DrugRepV_5378 | 5-fluorouridine | NA | Cancer | Lassa virus | Josiah | NA | Minigenome assays | Decrease (50 %) | Experimental | 27771389 |
DrugRepV_5379 | 8-Azaadenosine | NA | NA | Lassa virus | Josiah | NA | Minigenome assays | Decrease (50 %) | NA | 27771389 |
DrugRepV_5380 | 8-Azidoadenosine | NA | NA | Lassa virus | Josiah | NA | Minigenome assays | Decrease (50 %) | NA | 27771389 |
DrugRepV_5381 | Toyocamycin | NA | NA | Lassa virus | Josiah | NA | Minigenome assays | Decrease (50 %) | Experimental | 27771389 |
DrugRepV_5382 | 6-Azauridine | NA | Cancer | Lassa virus | Josiah | NA | Minigenome assays | Decrease (50 %) | NA | 27771389 |
DrugRepV_5383 | 8-Azaadenosine | NA | NA | Ebola virus | Ebola virus/H.sapiens-rec/LBR/2014/ Makona-L2014 | NA | Minigenome assays | Decrease (50 %) | NA | 27771389 |
DrugRepV_5384 | Toyocamycin | NA | NA | Ebola virus | Ebola virus/H.sapiens-rec/LBR/2014/ Makona-L2015 | NA | Minigenome assays | Decrease (50 %) | Experimental | 27771389 |
DrugRepV_5385 | 6-Azauridine | NA | Cancer | Ebola virus | Ebola virus/H.sapiens-rec/LBR/2014/ Makona-L2016 | NA | Minigenome assays | Decrease (50 %) | NA | 27771389 |